12 March 2008
Immtech Announces Update On Business Operations

22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine

19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008

13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor

11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results

06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008

28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM

26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold

05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

往新闻稿网页

从Adobe网站下载免费拷贝

Immtech Pharmaceuticals的目的...

Immtech旨在为影响全球数百万人的传染性疾病提供治疗及预防而获得可观利润。

技术

我们拥有全球独家专利的药物化学平臺以开发化合物﹐并使之商业化的。

往技术网页

使用条件 | 私隐条例
? 2007 Immtech. 版权所有